ARCHIVES

FDA approves Irinotecan, Days After ODAC Meeting

This article is from The Cancer Letter archive.

Vol. 22 No. 25 | June 21, 1996

Download PDF Visit The Full Archive

Related Articles

New NCI advisory Boards Appointed, Begin Review Of NCI Programs

March 29, 1996

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

RFP: Sole Source

May 12, 2000

Breast Cancer Action Plan Committee Outrages By Plans for $14M In NCI Funds

August 1, 1997

NIH Biennial Report Offers Research Portrait

September 24, 2010

In Brief: Upton Not Planning To Leave NCI, As Hinted By Califano, Over New Ethics Regulations

March 30, 1979